单心室分期姑息期间及术后机械性房室瓣置换的结局与危险因素
该回顾性研究纳入1997至2022年22例完成至少I期姑息后行机械性房室瓣置换的单心室患者,中位年龄1.7岁,院内死亡4例(18.2%),1年无移植生存率55.6%。
要点
- 单心室患者机械性房室瓣置换院内死亡率18.2%,1年无移植生存率55.6%。
- 术后心室功能减低与体外循环时间延长是死亡独立危险因素。
- 心室功能保留者1年生存率100%,显著优于功能受损者的25.7%。
核心结论
- 单心室患者行机械性房室瓣置换的结局取决于术后心室功能是否保留及既往瓣膜修复结果。
研究设计与样本
- 回顾性队列研究,纳入1997至2022年完成至少I期姑息后行机械性房室瓣置换的22例单心室患者。
主要发现
- 瓣膜置换中位年龄1.7岁(四分位距0.5-8.0岁),左心发育不良综合征最常见(n=10),Norwood手术为最常见I期姑息(n=13)。
- 14例在Fontan完成前或同期行瓣膜置换,8例在Fontan完成后行瓣膜置换;11例有既往房室瓣修复史,8例术中尝试修复后转为置换。
- 院内死亡4例(18.2%),1年无移植生存率55.6%。
临床怎么用
- 对单心室行房室瓣手术者应重视心室功能保护,心室功能受损者机械瓣置换预后差。
- 术前应充分评估瓣膜修复可能性,因修复失败转为置换者结局可能受影响。
局限性
- 回顾性设计、样本量小(22例),结果需更大规模研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Mechanical atrioventricular valve (AVV) replacement in single-ventricle patients carries significant risks with limited outcome data. We evaluated outcomes and identified risk factors for mortality after mechanical AVV replacement during staged Fontan palliation. METHODS: We retrospectively reviewed 22 patients who underwent mechanical AVV replacement from 1997 to 2022 after completing at least stage I palliation. Patients were stratified by early postoperative ventricular function (normal vs impaired) and timing of AVV replacement (primary vs post-AVV repair). The primary outcome was transplant-free survival. RESULTS: Median age at valve replacement was 1.7 years (interquartile range, 0.5-8.0 years). Hypoplastic left heart syndrome was the most common diagnosis (n = 10), and the Norwood procedure was the most frequent stage I palliation (n = 13). AVV replacement was performed before or at Fontan completion in 14 patients and after in 8 patients. A previous AVV repair was performed in 11 patients. Intraoperatively, 8 patients converted to AVV replacement after attempted AVV repair. There were 4 in-hospital deaths (18.2%). Transplant-free survival at 1 year was 55.6%. Postoperative reduced ventricular function (hazard ratio, 4.890; P = .018) and longer cardiopulmonary bypass time (hazard ratio, 1.013; P = .033) were risk factors for death. Patients with preserved ventricular function showed significantly better survival than those with impaired function (mild, moderate, or severe) (100% vs 25.7% at 1 year, P < .001). CONCLUSIONS: Approximately 1 in 10 single-ventricle patients undergoing AVV surgery required mechanical AVV replacement. Outcomes depend on the preserved ventricular function and the results of valve repair before AVV replacement.
引用
- Matsubara M, Deimel C, Schaeffer T, et al. Mechanical Atrioventricular Valve Replacement During and After the Single-Ventricle Palliation. Ann Thorac Surg. 2026. PMID: 41856345. doi:10.1016/j.athoracsur.2026.03.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。